Skip to main content

Table 4 Determinants of HR-HPV persistence for women with normal or mild cervical abnormality, for the folate sub-set; results of a multivariate analysis

From: Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study

Variable

Odds ratio [95% CI]

P value

Total sample

  

Folate [ng/mg]

1.065 [1.012; 1.120]

0.015

HPV-16 infection

1.509 [1.022; 2.228]

0.038

Multiple HR-HPV infections

1.440 [1.026; 2.019]

0.036

Normal cervical cytology

  

Age

1.031 [1.007; 1.055]

0.012

HPV-16 infection

1.915 [1.176; 3.119]

0.009

Multiple HR-HPV infections

1.570 [1.020; 2.416]

0.040

Mild cervical cytology

  

Age

0.925 [0.872; 0.982]

0.010

Folate [ng/mg]

1.144 [1.020; 1.282]

0.021

HPV-52 infections

4.924 [1.310; 18.513]

0.018

  1. HPV persistence refers to any HR-HPV infection at follow-up.